Class information for:
Level 1: NEDD9//HEF1//CRK

Basic class information

ID Publications Average number
of references
Avg. shr. active
ref. in WoS
13511 768 47.5 94%



Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)



ID, lev.
above
Publications Label for level above
313 17635 X LINKED AGAMMAGLOBULINEMIA//BRUTONS TYROSINE KINASE//BTK

Terms with highest relevance score



Rank Term Type of term Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
1 NEDD9 Author keyword 50 81% 4% 30
2 HEF1 Author keyword 32 80% 3% 20
3 CRK Author keyword 32 48% 6% 49
4 CRKL Author keyword 30 51% 5% 42
5 DOCK180 Author keyword 26 68% 3% 23
6 C3G Author keyword 24 59% 4% 27
7 P130CAS Author keyword 20 38% 5% 42
8 V CRK Author keyword 18 89% 1% 8
9 BCAR3 Author keyword 15 88% 1% 7
10 BCAR1 Author keyword 14 100% 1% 7

Web of Science journal categories

Author Key Words



Rank Web of Science journal category Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
LCSH search Wikipedia search
1 NEDD9 50 81% 4% 30 Search NEDD9 Search NEDD9
2 HEF1 32 80% 3% 20 Search HEF1 Search HEF1
3 CRK 32 48% 6% 49 Search CRK Search CRK
4 CRKL 30 51% 5% 42 Search CRKL Search CRKL
5 DOCK180 26 68% 3% 23 Search DOCK180 Search DOCK180
6 C3G 24 59% 4% 27 Search C3G Search C3G
7 P130CAS 20 38% 5% 42 Search P130CAS Search P130CAS
8 V CRK 18 89% 1% 8 Search V+CRK Search V+CRK
9 BCAR3 15 88% 1% 7 Search BCAR3 Search BCAR3
10 BCAR1 14 100% 1% 7 Search BCAR1 Search BCAR1

Key Words Plus



Rank Web of Science journal category Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
1 V CRK 85 59% 12% 95
2 HEF1 65 93% 3% 25
3 P130CAS 41 41% 10% 79
4 CAS L 41 85% 3% 22
5 C CRK 40 71% 4% 32
6 MYOBLAST CITY 28 64% 4% 28
7 SUBSTRATE LYMPHOCYTE TYPE 26 100% 1% 11
8 ADAPTER PROTEIN CAS 23 79% 2% 15
9 CRK 22 40% 6% 44
10 DOCKING PROTEIN HEF1 22 81% 2% 13

Journals

Reviews



Title Publ. year Cit. Active references % act. ref.
to same field
Preclinical and clinical studies of the NEDD9 scaffold protein in cancer and other diseases 2015 1 111 72%
GEF what? Dock 180 and related proteins help Rac to polarize cells in new ways 2007 135 49 57%
Integrin signalling adaptors: not only figurants in the cancer story 2010 122 151 31%
Crk and CrkL adaptor proteins: networks for physiological and pathological signaling 2009 78 201 49%
CAS proteins in normal and pathological cell growth control 2010 59 235 49%
p130Cas: a versatile scaffold in signaling networks 2006 171 87 46%
Insights into the biological functions of Dock family guanine nucleotide exchange factors 2014 12 94 36%
CAS Proteins in Health and Disease: An Update 2014 3 77 66%
Regulation of integrin-mediated cellular responses through assembly of a CAS/Crk scaffold 2004 106 153 45%
Integrin signalling: a new Cas(t) of characters enters the stage 2000 213 78 47%

Address terms



Rank Address term Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
1 MICROORGANISMS IMMUNIZAT 3 100% 0.4% 3
2 ADV IMMUNOL 3 32% 1.0% 8
3 IMMUNOGENETHIGASHI KU 2 50% 0.4% 3
4 IMMUNOBIOL NEUROSCI 2 11% 2.0% 15
5 RAYMOND BEVERLY SACKLER GENET MOL MED 2 22% 0.8% 6
6 TRANSLAT PATHOLKITA KU 1 100% 0.3% 2
7 BIO IMAGING CELL DYNAM 1 29% 0.5% 4
8 VISUAL PROJECT 1 24% 0.5% 4
9 FOCAL ADHES BIOL GRP 1 40% 0.3% 2
10 PROV CELL MOL BIOL 1 40% 0.3% 2

Related classes at same level (level 1)



Rank Relatedness score Related classes
1 0.0000160313 FOCAL ADHESION KINASE//FAK//PYK2
2 0.0000140303 GRB2//SH2 DOMAIN//SH3 DOMAIN
3 0.0000136671 CBL B//CBL//CIN85
4 0.0000128974 C ABL//BCR ABL//BCR ABL ONCOPROTEIN
5 0.0000127285 RAP1//EPAC//EPAC1
6 0.0000081283 TIAM1//RHOB//RHOGDI2
7 0.0000061735 PODOSOMES//INVADOPODIA//CORTACTIN
8 0.0000061315 VAV//VAV1//VAV3
9 0.0000059911 PAK4//PAK1//P21 ACTIVATED KINASE
10 0.0000052680 MFG E8//APOPTOTIC CELLS//CELL CLEARANCE